Artificial Intelligence Tool for Lung Cancer

SC
Overseen ByStudy Coordinator
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Northwestern University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This clinical trial studies whether an artificial intelligence (AI) software tool called iSeg can be safely and effectively used during routine radiation treatment planning for patients with lung tumors. Typical radiation treatment planning involves physicians manually outlining the tumors to plan where the radiation therapy will be delivered. This process can be time consuming and may vary between physicians. iSeg uses AI to analyze computed tomography (CT) images and generate a proposed tumor outline that can then be reviewed and modified by the treating physician during radiation treatment planning which may help improve accuracy and provide more consistent results and better planning. iSeg may be safe and effective to use during radiation treatment planning for patients with lung tumors.

Who Is on the Research Team?

ME

Mohamed E Abazeed

Principal Investigator

Northwestern University

Are You a Good Fit for This Trial?

This trial is for people diagnosed with lung tumors, including non-small cell lung cancer, who are scheduled to receive radiation therapy. Specific inclusion or exclusion criteria are not listed.

Inclusion Criteria

Patients must have radiographically measurable or evaluable disease per RECIST v.1.1
Patients of child-bearing potential (POCBP) must have a negative urine or serum pregnancy test prior to registration
I am 18 years old or older.
See 6 more

Exclusion Criteria

I have recovered from serious chest side effects from past cancer treatments.
I do not have oligo-persistent cancer.
I have had radiation therapy to the same area more than once.
See 6 more

What Are the Treatments Tested in This Trial?

Interventions

  • iSeg

Trial Overview

The study tests an AI software tool called iSeg that helps doctors outline lung tumors on CT scans during radiation treatment planning. The goal is to see if using iSeg makes the process safer, faster, and more accurate compared to standard manual methods.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Treatment (iSeg, SBRT)Experimental Treatment7 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Northwestern University

Lead Sponsor

Trials
1,674
Recruited
989,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+